EMA — authorised 23 February 2018
- Marketing authorisation holder: Roche Registration Limited
- Status: approved
EMA authorised Hemlibra on 23 February 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 23 February 2018.
Roche Registration Limited holds the EU marketing authorisation.